Research ArticleImages in Rheumatology
A Recurrent Central Band Keratopathy in a Child
Séverine Guillaume-Czitrom, Sophie Stephan and Bahram Bodaghi
The Journal of Rheumatology June 2021, jrheum.200462; DOI: https://doi.org/10.3899/jrheum.200462
Séverine Guillaume-Czitrom
Hôpital Universitaire de Bicêtre, Département de Médecine des Adolescents, APHP, Le Kremlin Bicêtre; Fondation Ophtalmologique de Rothschild, Département d'Ophtalmologie Paris; DHU Vision et Handicap, Hôpital Universitaire de la Pitié Salpétrière, Département d'Ophtalmologie, Université Pierre and Marie Curie, Sorbonne Universités, Paris, France. Address correspondence to Dr. S. Guillaume-Czitrom, Hôpital Universitaire de Bicêtre, Service de Médecine des Adolescents, APHP, 78 rue du Général Leclerc, 94270 Le Kremlin Bicêtre, France. The authors declare no conflicts of interest, including financial conflicts. Patient permission form was signed by the patient, after parents and patient were informed, and can be available upon request. Ethics committee approval was not asked since all elements of diagnosis and treatment belonged to current care; adalimumab has been approved for anterior chronic uveitis treatment in children by the European Commission since mid-2016.
Sophie Stephan
Hôpital Universitaire de Bicêtre, Département de Médecine des Adolescents, APHP, Le Kremlin Bicêtre; Fondation Ophtalmologique de Rothschild, Département d'Ophtalmologie Paris; DHU Vision et Handicap, Hôpital Universitaire de la Pitié Salpétrière, Département d'Ophtalmologie, Université Pierre and Marie Curie, Sorbonne Universités, Paris, France. Address correspondence to Dr. S. Guillaume-Czitrom, Hôpital Universitaire de Bicêtre, Service de Médecine des Adolescents, APHP, 78 rue du Général Leclerc, 94270 Le Kremlin Bicêtre, France. The authors declare no conflicts of interest, including financial conflicts. Patient permission form was signed by the patient, after parents and patient were informed, and can be available upon request. Ethics committee approval was not asked since all elements of diagnosis and treatment belonged to current care; adalimumab has been approved for anterior chronic uveitis treatment in children by the European Commission since mid-2016.
Bahram Bodaghi
Hôpital Universitaire de Bicêtre, Département de Médecine des Adolescents, APHP, Le Kremlin Bicêtre; Fondation Ophtalmologique de Rothschild, Département d'Ophtalmologie Paris; DHU Vision et Handicap, Hôpital Universitaire de la Pitié Salpétrière, Département d'Ophtalmologie, Université Pierre and Marie Curie, Sorbonne Universités, Paris, France. Address correspondence to Dr. S. Guillaume-Czitrom, Hôpital Universitaire de Bicêtre, Service de Médecine des Adolescents, APHP, 78 rue du Général Leclerc, 94270 Le Kremlin Bicêtre, France. The authors declare no conflicts of interest, including financial conflicts. Patient permission form was signed by the patient, after parents and patient were informed, and can be available upon request. Ethics committee approval was not asked since all elements of diagnosis and treatment belonged to current care; adalimumab has been approved for anterior chronic uveitis treatment in children by the European Commission since mid-2016.
Abstract
For the first time, to our knowledge, we present the case of a child with simultaneous occurrence of a C3-glomerulopathy and an anterior uveitis complicated with severe band keratopathy (BK). In addition, repeated evaluations of uveitis disclosed important differences between slit lamp and laser flare photometry (LFP) results due to BK, making treatment choice difficult.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
A Recurrent Central Band Keratopathy in a Child
Séverine Guillaume-Czitrom, Sophie Stephan, Bahram Bodaghi
The Journal of Rheumatology Jun 2021, jrheum.200462; DOI: 10.3899/jrheum.200462